Actinium Pharmaceuticals Inc (ATNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2015 | 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 19,285 | 6,707 | 11,751 | 14,671 | 5,878 |
| TOTAL | $19,919 | $7,407 | $12,423 | $15,279 | $6,546 |
| Non-Current Assets | |||||
| PPE Net | 101 | 128 | 141 | 133 | 14 |
| Investments And Advances | 0 | 0 | 35 | 35 | 0 |
| Other Non-Current Assets | 35 | 35 | 0 | 0 | 0 |
| TOTAL | $136 | $162 | $176 | $168 | $14 |
| Total Assets | $20,055 | $7,569 | $12,598 | $15,447 | $6,560 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,556 | 2,498 | 2,010 | 1,235 | 805 |
| Other current liabilities | 1,865 | 6,710 | 8,217 | 9,827 | 19,129 |
| TOTAL | $3,611 | $9,492 | $10,226 | $11,117 | $20,028 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $3,611 | $9,492 | $10,226 | $11,117 | $20,028 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,194 | 1,182 | 999 | 937 | 851 |
| Common Shares | 36 | 30 | 30 | 28 | 26 |
| Retained earnings | -94,280 | -91,205 | -85,779 | -79,702 | -83,217 |
| TOTAL | $16,445 | $-1,923 | $2,372 | $4,330 | $-13,468 |
| Total Liabilities And Equity | $20,055 | $7,569 | $12,598 | $15,447 | $6,560 |